Testing ifenprodil for nerve repair in multiple sclerosis
Part of Brain & nervous system, Immune system & allergy clinical trials.
This trial tests whether the drug ifenprodil can help repair the protective coating around nerves in people with relapsing-remitting MS. The goal is to see if it can improve vision-related nerve function, which may indicate overall nerve repair.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You have relapsing-remitting multiple sclerosis (RRMS).
- You have had no MS relapse (including optic neuritis) in the last 6 months.
- One of your eyes shows slower visual signals on a special test (VEP), and the nerve layer in that eye is thick enough (more than 70 micrometres).
- You can have an MRI and a PET scan (no metal implants, not over 140 kg, etc.).
- Your kidney and liver function tests are within safe limits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how aging affects the brain's ability to repair the protective coating around nerves (myelin) in people with MS. It tests methods to measure this repair process and may help find ways to slow down disability.
This study tests whether a medicine that targets a specific brain inflammation marker (TSPO) can help in people with certain types of multiple sclerosis. It focuses on safety and whether the target can be measured and influenced during treatment.
This trial tests an experimental drug called AZD0120 in adults with multiple sclerosis. It is designed for people with relapsing or progressive forms of MS who have not responded well to other treatments or have active disease.
This trial tests an experimental oral drug called VT7208 in both healthy volunteers and people with multiple sclerosis (MS). The goal is to see if it is safe and how the body processes it, which could lead to a new treatment option for MS.
This study tests whether adding a probiotic supplement to your usual MS treatment (or to no treatment) can help manage relapsing-remitting multiple sclerosis. It aims to see if the probiotic is safe and beneficial as an add-on therapy.
This trial uses brain MRI and eye imaging tests to study research markers in people with multiple sclerosis (MS) and related neurologic conditions. It may help researchers better understand these diseases and how they change over time.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.